Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Business Update

IDC Forecasts Spending on GenAI Solutions Will Reach $143 Billion in 2027 With a Five-Year Compound Annual Growth Rate of 73.3%


A new forecast from International Data Corporation (IDC) shows that enterprises will invest nearly $16 billion worldwide on GenAI solutions in 2023. This spending, which includes GenAI software as well as related infrastructure hardware and IT/business services, is expected to reach $143 billion in 2027 with a compound annual growth rate (CAGR) of 73.3% over the 2023-2027 forecast period. This is more than twice the rate of growth in overall AI spending* and almost 13 times greater than the CAGR for worldwide IT spending over the same period.

"Generative AI is more than a fleeting trend or mere hype. It is a transformative technology with far-reaching implications and business impact," says Ritu Jyoti, group vice president, Worldwide Artificial Intelligence and Automation market research and advisory services at IDC. "With ethical and responsible implementation, GenAI is poised to reshape industries, changing the way we work, play, and interact with the world."

IDC expects GenAI investments to follow a natural progression over the next several years as organizations transition from early experimentation to aggressive build out with targeted use cases to widespread adoption across business activities with an extension of GenAI use to the edge.

"The rate of GenAI spending will be somewhat constrained through 2025 due to turbulence in workload shifts and resource allocation, not just in silicon but also in networking, facilities, model confidence, and AI skills," noted Rick Villars, group vice president, Worldwide Research at IDC. "Other factors that might constrain the expected rate of investment include pricing, concerns about privacy and security, and the possibility of an existential crisis that triggers major consumer antipathy or government interventions."

By the end of the forecast, GenAI spending will account for 28.1% of overall AI spending, up significantly from 9.0% in 2023. GenAI spending will remain strong well beyond the build out phase as these solutions become a foundational element in enterprises' digital business control platforms.

GenAI infrastructure, including hardware, Infrastructure as a Service (IaaS), and system infrastructure software (SIS), will represent the largest area of investment during the build out phase. But GenAI services will gradually overtake infrastructure by the end of the forecast with a five-year CAGR of 76.8%. The GenAI software segments will see the fastest growth over the 2023-2027 forecast with GenAI platforms/models delivering a CAGR of 96.4% followed by GenAI application development & deployment (AD&D) and applications software with an 82.7% CAGR.

The IDC report, GenAI Implementation Market Outlook: Worldwide Core IT Spending for GenAI Forecast, 2023?2027 (Doc #US51294223), provides IDC's initial consolidated worldwide GenAI implementation forecast, providing insights on how, where, and when organizations will allocate their spending on core IT technology products/services to implement GenAI capabilities within their businesses from 2023 to 2027. More detailed forecasts, including the impact on end devices, network services, and software applications that are enhanced through incorporation of GenAI, will be published in the coming months.

* Note: Overall AI spending includes revenue for infrastructure hardware, software, and IT/business services to implement predictive, interpretive, and generative AI solutions. AI software includes application software, platforms/models, and application development & deployment software. AI applications must have an AI component that is crucial to the application (AI-centric) ? without this AI component the application will not function.

About IDC

International Data Corporation (IDC) is the premier global provider of market intelligence, advisory services, and events for the information technology, telecommunications, and consumer technology markets. With more than 1,300 analysts worldwide, IDC offers global, regional, and local expertise on technology, IT benchmarking and sourcing, and industry opportunities and trends in over 110 countries. IDC's analysis and insight helps IT professionals, business executives, and the investment community to make fact-based technology decisions and to achieve their key business objectives. Founded in 1964, IDC is a wholly owned subsidiary of International Data Group (IDG), the world's leading tech media, data, and marketing services company. To learn more about IDC, please visit www.idc.com. Follow IDC on Twitter at @IDC and LinkedIn. Subscribe to the IDC Blog for industry news and insights.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: